Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum.
about
Tranexamic acid for preventing postpartum haemorrhageTreatment for primary postpartum haemorrhageAntifibrinolytic therapy to reduce haemoptysis from any causeAntifibrinolytic therapy to reduce haemoptysis from any cause.Diagnosis and management of maternal thrombocytopenia in pregnancy.Tranexamic acid for the management of uterine fibroid tumors: A systematic review of the current evidence.Uterine balloon tamponade in combination with topical administration of tranexamic Acid for management of postpartum hemorrhage.Hemostatic resuscitation in postpartum hemorrhage - a supplement to surgery.Study protocol. TRAAP - TRAnexamic Acid for Preventing postpartum hemorrhage after vaginal delivery: a multicenter randomized, double-blind, placebo-controlled trial.Is prophylactic tranexamic acid administration effective and safe for postpartum hemorrhage prevention?: A systematic review and meta-analysis.Haemostatic monitoring during postpartum haemorrhage and implications for management.Update on inherited disorders of haemostasis and pregnancy.Treatment of Postpartum Hemorrhage With Blood Products in a Tertiary Hospital: Outcomes and Predictive Factors Associated With Severe HemorrhageComparative evaluation of two doses of tranexamic acid used prophylactically in anemic parturients for lower segment cesarean section: A double-blind randomized case control prospective trial.Management of pregnancy, labour and delivery in women with inherited bleeding disorders.Hemostatic disorders in women.Pregnancy complications and obstetric care in women with inherited bleeding disorders.Perinatal aspects of haemophilia.Prophylactic tranexamic acid in parturients at low risk for post-partum haemorrhage: systematic review and meta-analysis.A randomized placebo-controlled trial of preoperative tranexamic acid among women undergoing elective cesarean delivery.Causes and avoidable factors in maternal death due to cesarean-related hemorrhage in South Africa.Policy of high-dose tranexamic acid for treating postpartum hemorrhage after vaginal delivery.Role of Tranexamic Acid in Reducing Blood Loss in Vaginal Delivery.Tranexamic acid for the prevention of postpartum hemorrhage after cesarean section: a double-blind randomization trial.Tranexamic acid for cesarean section: a double-blind, placebo-controlled, randomized clinical trial.The effect of tranexamic acid on blood loss and maternal outcome in the treatment of persistent postpartum hemorrhage: A nationwide retrospective cohort study.The effect of prophylactic oral tranexamic acid plus buccal misoprostol on blood loss after vaginal delivery: a randomized controlled trial.Randomized controlled trial of tranexamic acid among parturients at increased risk for postpartum hemorrhage undergoing cesarean delivery.[Anesthesia in obstetrics: Tried and trusted methods, current standards and new challenges].Peripartum Haemorrhage: Haemostatic Aspects of the New German PPH Guideline.
P2860
Q24187146-64A215E5-A108-440A-BB13-F01AA5BE5E2FQ24200400-6A787BF3-DBA6-41C0-BAB0-0F9C75A4A562Q24200405-CE23ABFB-D84F-47EE-A4A0-522D76951F3FQ30241963-6413127F-5AA6-4E8E-9F1A-9EA302E9C7B8Q33401045-5702AD88-C10D-485D-8375-309B91E737E8Q34706222-0A7B176A-F8C1-40DD-BF4A-3C505663A81DQ35226731-BAEAFF56-9744-4EF3-BB29-D20B8B47905EQ35557436-86645C8B-40ED-48C8-8D2E-4859544BA6FBQ35662691-A4CD86C6-DB2D-4F85-AB2C-2BA6AC64C6BFQ36245378-71DCBDA2-0D0C-43C6-BCE8-2D75033E97DCQ36400893-545D9424-3C82-45A2-AC77-1A019C3055F6Q37107274-AA1A2752-A584-4F1D-8FA9-CC8E0045A725Q37220184-99C3BD34-E4E1-452D-A8EE-F4B2C2E8F2A1Q37382013-3F0518CD-C7FF-4D21-AAA4-36584E7BEAF5Q37892650-01A8F690-F584-423A-A172-74EE5B4D65FEQ38117734-14C67737-53FA-449C-ADBF-7A6CD8BC641CQ38150467-5EA76D0B-BFA6-4B7B-B2A8-B1AF32843516Q38222573-BD950274-7818-42E2-8E1B-D457FECC0DF0Q38234716-889257E5-9C76-49B3-AD6A-83DD1DC8FC43Q39202981-088B2860-B5A5-4B5B-AAB1-3958ADA19168Q40677971-B899C4E5-3E8A-4AA2-BBB3-5CB9423160BFQ41634937-674D4429-AD3A-45B7-AF63-9455B0B038E3Q41650663-5ECD1E34-4DF3-433F-B627-E3DD57EBD554Q43473466-3D4611DF-EB6C-4C55-8E7E-3F0D5B386D0DQ43971479-90D146CB-5497-4B36-B52F-6FBC5DB6F66EQ46301719-25AAA6A9-E082-4F16-B2E3-CD1DEBEFC124Q47192930-50344E3D-FCF1-4C8E-9780-5E422A4D62FEQ47581317-6F281AE0-D327-4626-8EF6-AC659FC07AAAQ51291214-07FF22D3-45C2-4603-B1C6-98757170E229Q55395624-65B73F11-EA60-4A88-AC83-BF8CA6D4E168
P2860
Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum.
@en
Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum.
@nl
type
label
Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum.
@en
Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum.
@nl
prefLabel
Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum.
@en
Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum.
@nl
P2860
P1476
Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum.
@en
P2093
Panagiotis Peitsidis
Rezan A Kadir
P2860
P304
P356
10.1517/14656566.2011.545818
P407
P577
2011-02-04T00:00:00Z